Jefferies Group's DERM Position Overview
Jefferies Group (via Jefferies Financial Group Inc.) currently holds 16,597 shares of Journey Medical Corporation (DERM) worth $117,507, representing 0.00% of the portfolio. First purchased in 2026-Q2, this recently established position has been held for 1 quarters.
Based on recent 13F filings, Jefferies Group has initiated a new position in DERM, representing a fresh investment thesis on this company. Insufficient history to summarize additions or reductions.
Analysis based on 13F filings available since 2013 Q2
Jefferies Group's Journey Medical Corporation (DERM) Holding Value Over Time
Track share changes against reported price movement
Quarterly Journey Medical Corporation (DERM) Trades by Jefferies Group
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2026 | +16,597 | New Buy | 16,597 | $7.08 |
Jefferies Group's Journey Medical Corporation Investment FAQs
Jefferies Group first purchased Journey Medical Corporation (DERM) in Q2 2026, acquiring 16,597 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Jefferies Group has held Journey Medical Corporation (DERM) for 1 quarters since Q2 2026.
Jefferies Group's largest addition to Journey Medical Corporation (DERM) was in Q2 2026, adding 16,597 shares worth $117,507.
According to the latest 13F filing for Q2 2026, Jefferies Group's firm, Jefferies Financial Group Inc., owns 16,597 shares of Journey Medical Corporation (DERM), valued at approximately $117,507.
As of the Q2 2026 filing, Journey Medical Corporation (DERM) represents approximately 0.00% of Jefferies Group's publicly disclosed stock portfolio, making it one of their key holdings.
Jefferies Group's peak holding in Journey Medical Corporation (DERM) was 16,597 shares, as reported at the end of Q2 2026.